RENE.L Share Chat (RENE)

Hi Epsilon,

Thanks for the speedy information, pleasing to hear that the shares will not disappear, I've had a look around the Computershare site, and based on the information there, I think the reason I didn't get any AGM details is that currently my shares are held in a Nominee account i.e. they are held in the platforms name rather than mine. I'm making enquires to see if I can get them moved to Computershare i my own name. I know they are not worth much but I've held them since about 2007

Once again thanks for your help, much appreciated

Hi,

You'll be pleased to know that your share holdings do not evaporate if the company goes private. It's your slice of the company and that's on file.

Shareholders (you) are recorded on the Shareholder Registry at

https://www.computershare.com/uk , and it is this company that is organising the proxy voting for the AGM. I think there are about 400 shareholders...some may have passed away of course!

You may be able to log in, after some effort, and cast your vote on the various Resolutions put forward via your computer. It may be possible to talk with them over the phone to explain your situation and I'm sure they'll help you with the logistics. Perhaps you may have moved house since buying shares so they may have sent stuff to the wrong house? Also take a look at the News section of the Reneuron website for information on the AGM Resolutions:

https://www.reneuron.com/wp-content/uploads/2025/11/ReNeuron-Group-plc-Circular-and-AGM-Notice.pdf

My guess is that shares will be able to be traded on a specialised platform if the Reneuron goes private. The Chairman has done this a few times with de-listed AIM companies - most, if not all, seem to have ended up on the JP Jenkins platform. https://www.jpjenkins.com/ . The website explains how to go about buying/selling the shares in their list of private/ de-listed companies.

Hi, Not sure if anyone could help with this query, but if anyone has anything information it would be greatly appreciated. I still hold Reneuron shares on 2 platforms, I didn't get any information regarding the AGM or any corporate actions notifications. Do I need to be re-registering them somewhere else, and what will happen to them if they go private? Thanks in advance if anyone has any information.

There are 5 Special Resolutions and 8 Ordinary Resolutions that will be voted on. The website details these, and how to vote by proxy if required. The most obvious of these is whether to take the company private or not.

Another one that caught my eye is the approval (or not) of 20.1m share options + 5.5m share allotment. Add these together and you get 25.6m. Before delisting there were 57.1m shares, so if these options mature there'll be 82.7m in total. Result? The insiders would have over 30% of the company. That "30%+" mark is significant.

Would like to know what the terms are. Any numbers whatsoever would be useful.

Life in the old dog yet ?

January 7th

htTps://www.laverocktx.com/news/reneuron-and-laverock-therapeutics-announce-collaboration-to-develop-in-vivo-gene-therapy-approaches

London, UK, 7th January 2026 – ReNeuron Group Limited, a biotechnology company harnessing the natural biology of exosomes to develop next-generation drug delivery systems, and Laverock Therapeutics (‘Laverock’), a company developing disease-responsive advanced therapies through its unique, programmable gene control technology, announce a collaboration to develop in-vivo gene therapy approaches based on both company’s platform technologies.

Https://www.reneuron.com/wp-content/uploads/2026/01/ReNeuron-Press-release-Jan-2026-CLEAN.pdf

It's not a private company yet, must be approved at the AGM first. Company will become ReNeuron Group Ltd. Rather than PLC.

New update on website, company declares good cash runway, potential deals on the horizon. However cannot organise trading platform at reasonable cost so can only offer their nominal 1p ordinary share value if anyone really wants to sell.

It's now a private company operating a low cash model, with good prospects. Drug delivery platforms can become highly valueable. Just can't cash out for fair value unless they relist( unlikely as their new model offers self financing low cost growth) so if they need capital they may list to raise it.

Future takeover is plausible but a lot needs to line up for that and if ever.

Should company prove its growth and income the cost of establishing trading in future may happen.

Received letter. Offered 1p per share. Given that the platform will also charge something, I dont see pretty much getting anything. Shall I sell or wait for a miraculous public opening, reorganised share that may hold some value?

Thanks, I didnt understand a word of what you said (probably not as well read as you might be!) but thanks for paying attention to the message! I have not been on this forum before, not know of anybody else who has been. I am not predicting future, only checked with AI, the status of companies that go under administration, are restructured and exit market. Essentially, it stated that post restructuring, there is nothing left in the company for the old shareholders except namesake, that remains on the sheets for legal reasons, but there is no value or remaining rights.

I do not know the truth, only shared, just in case others have more info to enlighten us.

Please feel free to share your knowledge and thoughts on the matter!

Akk2, are you by an chance a second cousin of Purpleacky, the prophetic poster on this board, the bone of rampers’ lives, the nemesis of Freddieboy, last seen riding his horse on Salcombe sands. In any event if you’re it’s pleasing to note your continuing interest and your intuitive use of AI to help foresee the future of a business, which like a mythical God may once again try to exert a seiren call. Welcome back!

Still holding a chunk of shares here and check this board every now and then. I think we are now stuck with Year End accounts and an AGM to find out how its going. Exosomes are the new kid on the block with massive potential if the science works. I have my hopes that Reneuron does unlock the drug delivery potential and in the next two or three years our remaining shares at least return some value.

If one or two decent phase 1 trials prove successful for large Pharma Co's we could even start to dream of 10p a share......😄😄

Don't know if anyone really comes on here now, but it would appear that we actually have a new and functional website (which looks significantly better than the old one). Maybe the lights are on and someone is home after all?

Results out soon according to Companies House

Thank you, appreciate it link.

It was in the Administrators Report. They got the finances in order and agreed a deal with FOSUN Pharmaceuticals whereby RENE took a small haircut on the £1m they were owed in return for renegotiated milestones/royalties

Page 5

Section 5.3 Book Debt

https://find-and-update.company-information.service.gov.uk/company/03375897/filing-history/MzQ1OTYwMTc1M2FkaXF6a2N4/document?format=pdf&download=0

Thanks for providing the information Narrative and the link, really useful, I've had a look round and as you say there are a few ex-AIM companies on there. I've found my missing shares I thought my provider had removed them because they ceased to exist when delisted, but they had just moved them to another account without telling me.

Thanks once again

Mr Ross has some experience of de-listing biotechs. These include AIM listed BiVictrix Therapeutics, Redx Pharma, and E-therapeutics. These all seem to have ended up on the JP Jenkins marketplace: https://jpjenkins.com/marketplace/

where they can be traded via various regulated brokers (they provide the definitive list on the website as well as the "price"). So I wouldn't be surprised if Reneuron ends up there too.

There is a registry of shareholders, which, I'm guessing, can be checked against to validate any selling or buying.

So will our shares still be registered somewhere as they have disappeared from my share accounts?

'Re-launch as a Private company focused on its stem cell line development expertise'

“Finally, as the Company is no longer a publicly listed company, I confirm our intention is to work closely with our existing shareholders to determine the best outcome for them including exploring options to allow shareholders to trade shares privately. Further details will be communicated in due course.”

A possible sign of life? Although I still wouldn't hold your breath.

ReNeuron Group plc, which has developed a proprietary stem cell-derived, exosome-based, drug delivery platform, announces that on 17th March 2025 the Company's administrators Cork Gully ("The Administrators") filed the relevant court documents to confirm that "the purpose of administration has been sufficiently achieved" and notice of the end of administration was filed with the court and the registrar of companies.

Iain Ross, Chairman, commented:

"During Administration, with the support and encouragement of the Administrators, Randolph Corteling, our Chief Scientific Officer, and I have explored the opportunity to re-launch and re-position ReNeuron as a private biotech company focused on its stem cell line development expertise, IP and know-how.

"I confirm that the Company has exited administration as a 'going concern' and has sufficient working capital to support its operations for a minimum of 12 months and has already identified a number immediate licence and fee generating opportunities.

"In addition, I am very pleased to announce that Randolph Corteling has been appointed as Managing Director and will lead the Company through its next phase of development. The ReNeuron Board will comprise myself as Chairman, with Barbara Staehelin remaining as Non-Executive Director and Chair of the Audit & Risk Committee and Randolph as Managing Director. Non-Executive Directors Michael Owen and Martin Walton have stood down from the Board effective today and I want to thank them not only for their unstinting support over the last few years but also for their support and wise counsel during the administration process.

"Finally, as the Company is no longer a publicly listed company, I confirm our intention is to work closely with our existing shareholders to determine the best outcome for them including exploring options to allow shareholders to trade shares privately. Further details will be communicated in due course."

I was in the vicinity on Friday so had a drive-by. Can confirm no sign of life in the building, no vehicles in the car park. Only some exterior lights left on.

6-monthly.

Surely, due another administrator progress Report 🤔

Https://find-and-update.company-information.service.gov.uk/company/03375897/filing-history

I bought Reneuron along with Summit on the same day about maybe 8 years back. I'd always bracketed them together in my mind as companies that would conquer disease and make me a few bob. Turns out I was half right - shame that Summit had to leave the UK and rely on a US billionaire to do it.

Yeah. Looks to me like they want to rinse whatever is left, rather than hand out the few remaining buttons to investors, before closing up shop for good.

Inconceivable that Iain will be able to secure something that delivers shareholder value now, versus presumably significant efforts to do so, prior to suspension.

Simply gives the impression of someone who is looking to claw back as much of the lost money from his own historic share purchases here as possible, from whatever cash is left in the business.

But I could be wrong and would be delighted, were this to prove otherwise.

Anyway, I hope you all have managed to regain your losses here and wish you all the best for the future.

Well at least we now have confirmation regarding the state of progress / administrators strategy for moving forwards.

Given the intended move to private entity status i am wondering how practical it prove to crystalize losses incurred here for set-off against gains elsewhere...the timeline to exit as a privately held entity being unknown with the resultant long-term lock in of losses for capital gains set-off purposes being far from an ideal scenario for private investors in what is effectively a failed entity...

Thought there would be more discussion on yesterday's news. There's a lot of people still holding this stock as far as I can recall. At least there's hope. I had written MMM off for years but that eventually returned and is now the same price as pre suspension

Still some life going by today's announcement, wish they would contact small pi's like me so we could take part

in any fundraising but naah that never happens

Why did Rene fail? Clearly its clinical trials failed, which is an understood risk, and it ran out of cash, which is also not surprising given the cost of developing a novel therapy far exceeds anything raised, but towards the end Rene seemed to have stumbled upon a unique even if unproven delivery mechanism? Yet Fosun seems to see little value, unless of course it’s licence deal allows free exploitation; Big Pharma, which has multi-billion dollar R&D budgets, equally seems unprepared to spend dimes buying Rene’s IPR. So were Rene so inept they were unable to convince others of concept or worth? Was the technology as good as we may have been led to believe? Or were we as shareholders sold a myth, while vested and perhaps incompetent interests drew down eye-watering salaries? I’ve no clue, but do understand that if the administrators suck a million bucks out of Fosun, that’s worth two cents a share ( less tax and fees of course😀). Nonetheless I enjoyed the banter and ride, even if an expensive one. The reality, we’re simply a statistic that makes up the 90+% of developments that fail. But it was always so; a punt that is now water under the Williamsburg bridge. Having said that I’m still expecting a cheque to cover a slab of Bud for some far off weekend. Have a good summer.

I'm a naturally pessimistic person but the way this is being drawn out would point towards some value.... whether we all benefit is of course a different matter

£1m hRPC milestone figure mentioned in there, which is interesting. What happens if the company is dissolved, and fosun take hRPC to market? Are those future milestones and any royalties ever payable at that point, in the unlikely event it does get to market?

'A licence agreement with a third party has given rise to a claim of £1,000,000 in relation to a payment for achieving an hRPC milestone. The estimated-to-realise value is given as £900,000, to account for tax that make become due upon receipt of payment. The Joint Administrators are currently assessing this position and intend to shortly commence action to recover any valid amounts due'

...probably not then after today's RNS.

Https://www.terrapinn.com/congress/advanced-therapies/speakers.stm

Evening grizzlyb

just popped in this evening, after a number of years, and whilst not surprised at all re the suspension i sincerely hope you haven't lost any money here

i remember well our discussions of old

bw for the future

and anyone else still here after all these years

jees at one point exosomes were only the icing on the cake

mol

RENE tried to raise funds last year and failed. The writing was on the wall then, if people chose not to see it then more fool them

I never understand why companies do not do a public fundraising where people can subscribe for stock at say 1.5p and see how much gets raised. I mean when HE1 raised at 0.2p everybody said game over diluted to oblivion but a short while later it 18 bags to 3.6p high. They might get £5-10 mil, so it's diluted but it gives them a chance, other stocks do not give a monkeys about doing this especially Vast who no matter how low continue to raise and dilute.

I'm sceptical this might be a fiddle when they do it this way and then flog whatever technology to management or "mates" who then disappear for a short while then refloat under a different name.

That is unnecessarily harsh. People did read the RNS. And some decided it was worth the risk to remain and see if they could get a raise or some other finance arrangement in place.

We were led to believe that they had something of value. That was clearly misleading, as evidenced by the lights out.

As I said the other day, if it were otherwise, then the BOD would have put forward a proposition to shareholders that included significant inside participation. Which, IMO, they would have got it away. I would have supported it, with the right conditions, for example.

As to the other poster's comment about the trades: no idea. It would be good to know. Especially if it was any of the RENE staff. But I guess we never will. GLA.

During thelast AGM there was a resolution giving authority to the management to dilute the stock up to 20% for a capital raise (direct/indirect), if needed.

What I don't understand is this; exactly one month ago before the last RNS 11m shares were 'traded', mainly off market. That's about 20% of the stock, with not one TR-1 form published. Okay, some retail shareholders bought or sold at the same time, but the large trades remain a mystery to me. Could they be linked to a short or some other off market financial instrument? Views anyone?

Much appreciated!

I have added this link for info purposes.

https://companieshouse.blog.gov.uk/2019/02/27/what-does-going-into-administration-mean/

Usually eight weeks from the appointment of the administrator, so we're looking at around the end of March.

Does anyone know the timeline for the company being wound up?

Balerno, incorrect on both accounts. It IS NOT in administration , yet. re read the RNS. Also there is no talk of pre pack admin - that is normally when say a company has a new vehicle lined up to buy the company for a nominal amount. No talk of that. Why did you post that?

So it’s been placed into administration. It’s not a liquidation so there may be a prepack or the components will be sold off. There is a factory plus the IP. Watch this space for redundancy announcements. Given the precarious nature of the finances then these are the options where the vultures can get cheap pickings. Hope we get the forms from the administrators soon.

I've gone right off Pharma/Bio's just wish I had sold the lot in Agl above 35p recently instead of a %.

I wonder if the mm's knew but if they did they would have spiked it to encourage more buying.

I'll write it off then hope for a % back if they lay off all staff and get any price for parts.

Indeed. I also hope that none of them sold any shares today, or in the last week or so.

Not that the regulators would do anything anyway, if it came to it, I suspect.

They should NOT have said they had cash till end of Q1 if they knew they would need cash early for creditors.

I'm not out of pocket much, but I am annoyed this has happened so early.

I say more likely, but I guess they have spunked a fair bit to get to this point.

More likely they have retained capital to cover redundancies and creditors rather than spunking the whole lot.

Will anyone buy the company as a going concern? Possible but chances are less than 10% imv. The chinese partner may take a look but who knows?

I’m so sorry for LTHs of which I was one once - paying several £s equivalent to today’s sp when Woodford was heavily into it. I sold out 2 years back at 44p - I couldn’t take the strain anymore. At even that sp I lost a bucketful.

Hope something turns up for you. ATB

Someone is going to pick up some very cheap patents and run with them at the expence of all us LTSH

News doesn't look good. Many years ago I was into this. Feel for investors here but management has spaffed so much money away over the years. Good luck to you all.

Must be tiny. For the last 2 weeks I've noticed the price jump up and down on tiny volume, one minute somebody is getting fleeced selling below the bid then the next day it's premiums being paid. Today at 3.5p offer they charge 3.6p for 60k and it's NT yet they dropped it yesterday making it out to look all terrible which I know to be bull. If this dropped positive news there is no seller or overhang to stop it, it would just take off. Could get over 4p today on any little demand as it's NT now to buy

Don't take it personally.

Share holders get another kick in the teeth.

Https://www.theguardian.com/science/2024/jan/31/gene-therapy-hailed-as-medical-magic-wand-for-hereditary-swelling-disorder

Note that CRISPR needs a delivery system...

Presumably the company could run out of cash, be taken private by the directors, and then sold on. So yes, a deal could be done at the lowest possible share price. But not in the interests of the current shareholders!

If a deal gets done, presumably it will be at the lowest possible share price, i.e. as close to the deadline as possible. Is my thinking on this correct?

So yesterday people were selling way below the bid and today somebody buys 120k and pays a big premium, they are taking the mick with this stock, any interest and this will spike to 5p again. There is not that much stock to play with

Heading for another low. The thing is it will be exceptionally hard for anybody to believe in Rene, rumours and bulls t no positive news nearly 10% down in one day, how long can this company carry on!

As usual, the buy/sell indicators with this one are IMO way off-beam. Not sure how they do it but I am sure the brokers do it. So I wouldn't be at all surprised to see an increase by end of day as I still feel someone/thing is accumulating here, with a lot of patience. On the other hand I wouldn't be surprised to see the price fall by the end of the day.... c'est la vie.

OK the 25k trade 4.05p is my buy. Yes I know it’s a pure binary punt. £1k which I can write off if necessary but the upside (if it were to happen) fwiw is worth the risk imo.

I know the bear points - ie.administration quite possible

The bull points:

Iain Ross - track record in industry redx Pharma etc

Biotech sector showing signs of life?

So much R&D here - all goes to waste?

Praised by unnamed Pharma industry partner

Exosome sector due to grow substantially in coming decade with lots more R&D

We’ll see. I won’t have long to wait

... of last week's frenzy? Someone much bigger wants this and it leaked. Everyone in on the leak rushed in to get their share until they were satisfied, knowing approximately what the outcome would be. No further insiders in the know so buying stopped and now they wait. I'm hoping not for long. Fanciful, yes, but we've seen everything over the last few years...